Grant for RXR Project

Acelot has been awarded a prestigious SBIR Phase I Grant from the NIH to identify novel RXR agonists for Alzheimer’s Disease. Acelot is
partnering with the Neuroscience Research Institute at UC Santa Barbara to discover and characterize new drug candidates.